Why weight loss drug adverts have been banned for the first time in the UK IN FULL The Independent UK · 18h ago
Watchdog bans first ads for oral weight loss medicines The ASA said the rulings were part of wider action to tackle irresponsible ads for weight loss medicines. Evening Standard · Oct 6
First ads for ‘powerful’ weight loss pills banned by watchdog The ASA warned that advertisers needed to consider the overall impression of an advert The Independent UK · Oct 6
Hair Loss Was Just the Start? The Nail Truth Hair shedding became one of the most talked-about cosmetic complaints linked with GLP-1 medicines. Now, researchers have found another change that is drawing attention: nail problems. A study presented at the 2026 European Academy of Dermatology and Venereology (EADV) Congress found that nail detachment was reported by 39% of GLP-1… MyLifeXP · Oct 5
GLP-1 Users Reported Nail Detachment Four Times as Often as Nonusers in an Early International Dermatology Survey GLP-1 users reported nail detachment four times as often as nonusers in an early EADV survey. See what the nail and hair data show and do not prove. Medical Daily · Oct 4
Rhode Island Medicaid Ends Coverage of Wegovy, Zepbound, and Other GLP-1 Drugs Prescribed Only for Weight Loss Rhode Island Medicaid stopped covering Wegovy, Zepbound, Saxenda, and Foundayo for weight loss on Oct. 1, 2026. Diabetes coverage continues. Here is what members should know. Medical Daily · Oct 3
Lilly's Foundayo Pill Linked to 57% Lower Predicted Diabetes Risk in ATTAIN-1 Modeling, but No Cases Were Counted A Lilly-funded modeling analysis tied Foundayo to a 57% lower predicted 10-year diabetes risk. No actual diabetes cases were counted in the study. Medical Daily · Oct 3
Peer-Reviewed Retatrutide Data Show 23.4% Weight Loss in Adults with Diabetes and BMI of 35 or Higher Full Lancet results for Lilly's retatrutide show 23.4% weight loss in adults with type 2 diabetes and a BMI of 35 or higher. The drug remains unapproved. Medical Daily · Oct 2
Participants Taking CagriSema Showed Changed Brain Responses to High-Calorie Food Images in Novo Study as FDA Decision Nears Novo says brain scans showed CagriSema changed food-cue responses and cut cravings. The data are early, and an FDA decision is expected in late 2026. Medical Daily · Oct 2
Lilly's Eloralintide Plus Tirzepatide Produced 23.3% Weight Loss in Phase 2 Trial of Adults with Type 2 Diabetes Lilly's eloralintide plus tirzepatide produced 23.3% weight loss vs 14.8% for tirzepatide alone in a Phase 2 diabetes trial. Here's the catch. Medical Daily · Oct 2
Lancet Publishes Full Petrelintide Trial: About 10% Weight Loss, Nausea in 20% as Amylin Drug Enters Phase 3 Full Phase 2 results for petrelintide in The Lancet show about 10% weight loss and nausea in 20%. What the experimental amylin drug means for patients. Medical Daily · Oct 1
New weight loss drug combination helps patients lose 54 pounds in less than a year Combining Mounjaro and Elora helped patients to shed almost a quarter of their body weight on average The Independent UK · Oct 1
Newsom Signs Law Barring Sales of Diet Pills and Weight-Loss Supplements to California Minors Without a Prescription California's AB 2030 bars sales of diet pills and weight-loss or muscle-building supplements to minors without a prescription. What parents should know. Medical Daily · Oct 1
Foundayo Pill Edged Higher-Dose Oral Semaglutide on Weight and A1C in Lilly's Indirect Type 2 Diabetes Analysis Lilly's indirect analysis found Foundayo 17.2 mg edged oral semaglutide 25 mg on weight and A1C in type 2 diabetes, but the gaps were modest. Medical Daily · Oct 1
Barchart · Sep 30 Eli Lilly vs. Novo: The Hidden Battle Behind the Weight-Loss Platform Reshaping Industries GLP-1 is a drug platform, not one product. Lilly leads; Novo slips; Pfizer, Amgen, Roche, and AbbVie chase, with pricing, generic and trial risks.
The Economic Times · Sep 30 What happens when middle-aged adults take creatine for 12 weeks? New study finds muscle gains even without structured exercise A recent study found that creatine supplementation can increase lean muscle tissue in middle-aged adults. Participants aged 45 to 65 who took creatine gained muscle even without exercise. Those who incorporated exercise and a calorie-reduced diet showed even greater improvements in strength. Additionally, creatine helped preserve muscle during weight loss…
Bored Panda · Sep 30 Doctor Weighs In After Hollywood Veteran’s Dramatic Weight Loss Has Everyone Making The Same Observation John Goodman’s dramatically slimmer appearance has sent fans into a frenzy, with many questioning whether weight-loss medication played a role in his astonishing transformation. An expert now explains what his appearance can and cannot reveal.
The Independent UK · Sep 30 New weight loss drug Retatrutide leads to dramatic results in trials IN FULL
The Independent UK · Sep 29 Breakthrough weight-loss drug helps diabetes patients lose a quarter of their body weight Eli Lilly’s retatrutide works by imitating three separate hormones to manage appetite, blood sugar and metabolism
Evening Standard · Sep 29 John Goodman shows off staggering weight loss in rare red carpet appearance with wife The Hollywood star has lost more than 14 stone after giving up drinking back in 2007
Medical Daily · Sep 29 Wegovy Users with Heart Disease May Get Protection Beyond Weight Loss, but Researchers Still Cannot Explain Why A new SELECT analysis finds Wegovy's heart benefit is not fully explained by weight loss or other known risk factors. Here is what it means for patients.
The Conversation · Sep 28 Do calorie-restricted diets work? Or will I just re-gain the weight? In the last few years, there’s been a lot of interest in calorie-restricted diets for weight loss.
Medical Daily · Sep 28 Retatrutide Diabetes Results, Mounjaro Heart Data, and Wegovy Pill Switching Study Lead EASD 2026 Meeting Opening in Milan EASD 2026 opens in Milan with retatrutide, Mounjaro heart, and Wegovy pill data due this week. Here is the schedule and what the numbers show.
MyLifeXP · Sep 28 New Test May Detect Pancreatic Cancer Before Symptoms Pancreatic cancer is often difficult to detect in its early stages because it may cause few clear symptoms at first. By the time signs become noticeable, the disease can already be advanced. Now, researchers are studying a blood test that may help identify pancreatic cancer earlier by detecting biological clues…
Evening Standard · Sep 26 Why a mono-diet could be the secret to weight loss Sometimes boring is best, says nutritionist Louise Pyne